New R&D DEPARTMENT
To deliver on our vision, we moved into one of the biggest healthcare research campus in Europe.
ZEKMED offers Cost-effective COVID19 supplies, rapidly and in scale, based on its alliance with its partners, with facilities located in Switzerland, Germany and China. We embrace the combination of two branches - Consumer and Commodity - to provide an offer relevant to all stakeholders worldwide whilst regarding long term sustainability.
Addressing both contemporary and future needs for pre diagnosis supplies is our mission in becoming a key player in helping the world adapt to the new normal.
Offering unrestricted access to meet client's manufacturing needs across the entire COVID19 spectrum of products.
We believe every one of our clients deserves dignity, choice and independence. We constantly strive to provide consistent and high-quality products. We’re here to help in any way we can. .
Antibodies are proteins created by the body’s immune system to fight a particular virus, such as SARS-CoV-2.
Antibody tests check your blood by looking for antibodies, which may tell you if you had a past infection with the virus that causes COVID-19.
WHO, supports these studies, as they are critical for understanding the extent of – and risk factors associated with – infection
The point of an antigen test is to detect the presence of a protein—the nucleocapsid protein—which is part of the SARS-CoV-2 virus that is the cause of COVID-19.
One type of rapid diagnostic test (RDT) detects the presence of viral proteins (antigens) expressed by the COVID-19 virus in a sample from the respiratory tract of a person.
The antigen(s) detected are expressed only when the virus is actively replicating; therefore, such tests are best used to identify acute or early infection.
15 Minutes Antibody and Antigen Rapid Test kits.
5 Minutes Hybrid Antibody-Antigen & A&B Influenza Rapid Test kits.
SARS2 Cov19 Vaccine R&D Department
Building the foundation for advanced A.I. assisted Pre Diagnosis in Switzerland.
To deliver on our vision, we moved into one of the biggest healthcare research campus in Europe.
We quickly utilised our network of partners, and know-how in the field of pre-diagnosis to develop the components for our COVID-19 Rapid test kits.
As electronic ID’s expand dramatically around the world, ZEKMED is committed to develop capabilities that deliver a better and more secure identification experience, while seamlessly checking on your healh.
When the world was initially struck with the outbreak of the COVID-19 pandemic in December 2019, and by January 2020 it soon became clear that this was going to be an international public health emergency. As few countries went into lockdown, it was clear that others will follow and the virus was going to spread. The key to containing this flu like virus was going to be through testing.
We quickly utilised our network of partners, and know-how in the field of pre-diagnosis to develop the components for our COVID-19 IGG/IGM and Antigen Rapid test kit which is identified under our brand name of ZEKMED. Since ZEKMED initial creation, we have continued to improve the accuracy and quality of the ZEKMED rapid test with our partners.